• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  coregeninc.com

CoRegen is involved in the development of cancer therapies that empower the immune system to eradicate cancer. The company has identified a key gene that can be engineered to enable the destruction of cancer cells. It has partnerships with research institutions and claims preclinical results on aggressive forms of cancer.